Cargando…

Zynteglo: Betibeglogene autotemcel – An innovative therapy for β- thalassemia patients

Detalles Bibliográficos
Autores principales: Asghar, Adam Ali, Khabir, Yumna, Hashmi, Mahnoor Rehan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577626/
https://www.ncbi.nlm.nih.gov/pubmed/36268391
http://dx.doi.org/10.1016/j.amsu.2022.104624
_version_ 1784811797344157696
author Asghar, Adam Ali
Khabir, Yumna
Hashmi, Mahnoor Rehan
author_facet Asghar, Adam Ali
Khabir, Yumna
Hashmi, Mahnoor Rehan
author_sort Asghar, Adam Ali
collection PubMed
description
format Online
Article
Text
id pubmed-9577626
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-95776262022-10-19 Zynteglo: Betibeglogene autotemcel – An innovative therapy for β- thalassemia patients Asghar, Adam Ali Khabir, Yumna Hashmi, Mahnoor Rehan Ann Med Surg (Lond) Short Communication Elsevier 2022-09-13 /pmc/articles/PMC9577626/ /pubmed/36268391 http://dx.doi.org/10.1016/j.amsu.2022.104624 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Short Communication
Asghar, Adam Ali
Khabir, Yumna
Hashmi, Mahnoor Rehan
Zynteglo: Betibeglogene autotemcel – An innovative therapy for β- thalassemia patients
title Zynteglo: Betibeglogene autotemcel – An innovative therapy for β- thalassemia patients
title_full Zynteglo: Betibeglogene autotemcel – An innovative therapy for β- thalassemia patients
title_fullStr Zynteglo: Betibeglogene autotemcel – An innovative therapy for β- thalassemia patients
title_full_unstemmed Zynteglo: Betibeglogene autotemcel – An innovative therapy for β- thalassemia patients
title_short Zynteglo: Betibeglogene autotemcel – An innovative therapy for β- thalassemia patients
title_sort zynteglo: betibeglogene autotemcel – an innovative therapy for β- thalassemia patients
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577626/
https://www.ncbi.nlm.nih.gov/pubmed/36268391
http://dx.doi.org/10.1016/j.amsu.2022.104624
work_keys_str_mv AT asgharadamali zynteglobetibeglogeneautotemcelaninnovativetherapyforbthalassemiapatients
AT khabiryumna zynteglobetibeglogeneautotemcelaninnovativetherapyforbthalassemiapatients
AT hashmimahnoorrehan zynteglobetibeglogeneautotemcelaninnovativetherapyforbthalassemiapatients